HEADER LIGASE 13-JUL-06 2DTO TITLE CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII TITLE 2 OT3 COMPLEXED WITH ATP AND BIOTIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: 235AA LONG HYPOTHETICAL BIOTIN--[ACETYL-COA-CARBOXYLASE] COMPND 3 LIGASE; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: BIOTIN PROTEIN LIGASE; COMPND 6 EC: 6.3.4.15; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PYROCOCCUS HORIKOSHII; SOURCE 3 ORGANISM_TAXID: 70601; SOURCE 4 STRAIN: OT3; SOURCE 5 GENE: BIRA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: (DE3)RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET 11A KEYWDS BIOTIN BIOSYNTHESIS, DIMER, STRUCTURAL GENOMICS, NPPSFA, NATIONAL KEYWDS 2 PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN KEYWDS 3 STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR B.BAGAUTDINOV,N.KUNISHIMA,RIKEN STRUCTURAL GENOMICS/PROTEOMICS AUTHOR 2 INITIATIVE (RSGI) REVDAT 5 15-NOV-23 2DTO 1 REMARK REVDAT 4 25-OCT-23 2DTO 1 REMARK SEQADV LINK REVDAT 3 13-JUL-11 2DTO 1 VERSN REVDAT 2 24-FEB-09 2DTO 1 VERSN REVDAT 1 13-JAN-07 2DTO 0 JRNL AUTH B.BAGAUTDINOV,N.KUNISHIMA JRNL TITL LIGAND STRUCTURES OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS JRNL TITL 2 HORIKOSHII OT3 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.68 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 69713 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.207 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 3546 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2790 REMARK 3 BIN FREE R VALUE : 0.2860 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 336 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3674 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 94 REMARK 3 SOLVENT ATOMS : 653 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.39000 REMARK 3 B22 (A**2) : -3.50000 REMARK 3 B33 (A**2) : 4.89000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.27000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.17 REMARK 3 ESD FROM SIGMAA (A) : 0.16 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.19 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.18 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.890 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : OVERALL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2DTO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-JUL-06. REMARK 100 THE DEPOSITION ID IS D_1000025830. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-MAY-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL26B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 69713 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : 0.04200 REMARK 200 FOR THE DATA SET : 18.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.34000 REMARK 200 R SYM FOR SHELL (I) : 0.30200 REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 2FYK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG20K, ACETATE, NAOH, PH 5.2, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.42500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A DIMER AND ITS COPY IS BUILD IN REMARK 300 THE ASYMMETRIC UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4730 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 8 -61.17 -122.01 REMARK 500 LYS A 120 96.94 -169.01 REMARK 500 VAL A 132 -79.18 -110.75 REMARK 500 ASP A 206 -173.75 177.78 REMARK 500 VAL B 132 -77.42 -111.46 REMARK 500 ASP B 197 104.65 -58.75 REMARK 500 ASP B 206 -178.57 -174.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A 1301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP B 1302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BTN A 1401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BTN B 1402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2FYK RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEX WITH ADP AND BIOTIN REMARK 900 RELATED ID: 1X01 RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEX WITH ATP REMARK 900 RELATED ID: PHO001000147.12 RELATED DB: TARGETDB DBREF 2DTO A 1 235 UNP O57883 O57883_PYRHO 1 235 DBREF 2DTO B 1 235 UNP O57883 O57883_PYRHO 1 235 SEQADV 2DTO MSE A 1 UNP O57883 MET 1 MODIFIED RESIDUE SEQADV 2DTO MSE A 44 UNP O57883 MET 44 MODIFIED RESIDUE SEQADV 2DTO MSE A 143 UNP O57883 MET 143 MODIFIED RESIDUE SEQADV 2DTO MSE A 176 UNP O57883 MET 176 MODIFIED RESIDUE SEQADV 2DTO MSE A 186 UNP O57883 MET 186 MODIFIED RESIDUE SEQADV 2DTO MSE B 1 UNP O57883 MET 1 MODIFIED RESIDUE SEQADV 2DTO MSE B 44 UNP O57883 MET 44 MODIFIED RESIDUE SEQADV 2DTO MSE B 143 UNP O57883 MET 143 MODIFIED RESIDUE SEQADV 2DTO MSE B 176 UNP O57883 MET 176 MODIFIED RESIDUE SEQADV 2DTO MSE B 186 UNP O57883 MET 186 MODIFIED RESIDUE SEQRES 1 A 235 MSE LEU GLY LEU LYS THR SER ILE ILE GLY ARG ARG VAL SEQRES 2 A 235 ILE TYR PHE GLN GLU ILE THR SER THR ASN GLU PHE ALA SEQRES 3 A 235 LYS THR SER TYR LEU GLU GLU GLY THR VAL ILE VAL ALA SEQRES 4 A 235 ASP LYS GLN THR MSE GLY HIS GLY ARG LEU ASN ARG LYS SEQRES 5 A 235 TRP GLU SER PRO GLU GLY GLY LEU TRP LEU SER ILE VAL SEQRES 6 A 235 LEU SER PRO LYS VAL PRO GLN LYS ASP LEU PRO LYS ILE SEQRES 7 A 235 VAL PHE LEU GLY ALA VAL GLY VAL VAL GLU THR LEU LYS SEQRES 8 A 235 GLU PHE SER ILE ASP GLY ARG ILE LYS TRP PRO ASN ASP SEQRES 9 A 235 VAL LEU VAL ASN TYR LYS LYS ILE ALA GLY VAL LEU VAL SEQRES 10 A 235 GLU GLY LYS GLY ASP LYS ILE VAL LEU GLY ILE GLY LEU SEQRES 11 A 235 ASN VAL ASN ASN LYS VAL PRO ASN GLY ALA THR SER MSE SEQRES 12 A 235 LYS LEU GLU LEU GLY SER GLU VAL PRO LEU LEU SER VAL SEQRES 13 A 235 PHE ARG SER LEU ILE THR ASN LEU ASP ARG LEU TYR LEU SEQRES 14 A 235 ASN PHE LEU LYS ASN PRO MSE ASP ILE LEU ASN LEU VAL SEQRES 15 A 235 ARG ASP ASN MSE ILE LEU GLY VAL ARG VAL LYS ILE LEU SEQRES 16 A 235 GLY ASP GLY SER PHE GLU GLY ILE ALA GLU ASP ILE ASP SEQRES 17 A 235 ASP PHE GLY ARG LEU ILE ILE ARG LEU ASP SER GLY GLU SEQRES 18 A 235 VAL LYS LYS VAL ILE TYR GLY ASP VAL SER LEU ARG PHE SEQRES 19 A 235 LEU SEQRES 1 B 235 MSE LEU GLY LEU LYS THR SER ILE ILE GLY ARG ARG VAL SEQRES 2 B 235 ILE TYR PHE GLN GLU ILE THR SER THR ASN GLU PHE ALA SEQRES 3 B 235 LYS THR SER TYR LEU GLU GLU GLY THR VAL ILE VAL ALA SEQRES 4 B 235 ASP LYS GLN THR MSE GLY HIS GLY ARG LEU ASN ARG LYS SEQRES 5 B 235 TRP GLU SER PRO GLU GLY GLY LEU TRP LEU SER ILE VAL SEQRES 6 B 235 LEU SER PRO LYS VAL PRO GLN LYS ASP LEU PRO LYS ILE SEQRES 7 B 235 VAL PHE LEU GLY ALA VAL GLY VAL VAL GLU THR LEU LYS SEQRES 8 B 235 GLU PHE SER ILE ASP GLY ARG ILE LYS TRP PRO ASN ASP SEQRES 9 B 235 VAL LEU VAL ASN TYR LYS LYS ILE ALA GLY VAL LEU VAL SEQRES 10 B 235 GLU GLY LYS GLY ASP LYS ILE VAL LEU GLY ILE GLY LEU SEQRES 11 B 235 ASN VAL ASN ASN LYS VAL PRO ASN GLY ALA THR SER MSE SEQRES 12 B 235 LYS LEU GLU LEU GLY SER GLU VAL PRO LEU LEU SER VAL SEQRES 13 B 235 PHE ARG SER LEU ILE THR ASN LEU ASP ARG LEU TYR LEU SEQRES 14 B 235 ASN PHE LEU LYS ASN PRO MSE ASP ILE LEU ASN LEU VAL SEQRES 15 B 235 ARG ASP ASN MSE ILE LEU GLY VAL ARG VAL LYS ILE LEU SEQRES 16 B 235 GLY ASP GLY SER PHE GLU GLY ILE ALA GLU ASP ILE ASP SEQRES 17 B 235 ASP PHE GLY ARG LEU ILE ILE ARG LEU ASP SER GLY GLU SEQRES 18 B 235 VAL LYS LYS VAL ILE TYR GLY ASP VAL SER LEU ARG PHE SEQRES 19 B 235 LEU MODRES 2DTO MSE A 1 MET SELENOMETHIONINE MODRES 2DTO MSE A 44 MET SELENOMETHIONINE MODRES 2DTO MSE A 143 MET SELENOMETHIONINE MODRES 2DTO MSE A 176 MET SELENOMETHIONINE MODRES 2DTO MSE A 186 MET SELENOMETHIONINE MODRES 2DTO MSE B 1 MET SELENOMETHIONINE MODRES 2DTO MSE B 44 MET SELENOMETHIONINE MODRES 2DTO MSE B 143 MET SELENOMETHIONINE MODRES 2DTO MSE B 176 MET SELENOMETHIONINE MODRES 2DTO MSE B 186 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 44 8 HET MSE A 143 8 HET MSE A 176 8 HET MSE A 186 8 HET MSE B 1 8 HET MSE B 44 8 HET MSE B 143 8 HET MSE B 176 8 HET MSE B 186 8 HET ATP A1301 31 HET BTN A1401 16 HET ATP B1302 31 HET BTN B1402 16 HETNAM MSE SELENOMETHIONINE HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE HETNAM BTN BIOTIN FORMUL 1 MSE 10(C5 H11 N O2 SE) FORMUL 3 ATP 2(C10 H16 N5 O13 P3) FORMUL 4 BTN 2(C10 H16 N2 O3 S) FORMUL 7 HOH *653(H2 O) HELIX 1 1 SER A 21 SER A 29 1 9 HELIX 2 2 GLY A 47 ARG A 51 5 5 HELIX 3 3 PRO A 71 PRO A 76 5 6 HELIX 4 4 LYS A 77 PHE A 93 1 17 HELIX 5 5 SER A 142 GLY A 148 1 7 HELIX 6 6 PRO A 152 ASN A 174 1 23 HELIX 7 7 MSE A 176 MSE A 186 1 11 HELIX 8 8 SER B 21 SER B 29 1 9 HELIX 9 9 GLY B 47 ARG B 51 5 5 HELIX 10 10 PRO B 71 PRO B 76 5 6 HELIX 11 11 LYS B 77 PHE B 93 1 17 HELIX 12 12 SER B 142 GLY B 148 1 7 HELIX 13 13 PRO B 152 ASN B 174 1 23 HELIX 14 14 MSE B 176 ASP B 184 1 9 SHEET 1 A14 ARG A 98 LYS A 100 0 SHEET 2 A14 ASP A 104 VAL A 107 -1 O LEU A 106 N ARG A 98 SHEET 3 A14 LYS A 110 GLY A 119 -1 O ILE A 112 N VAL A 105 SHEET 4 A14 ILE A 124 LEU A 130 -1 O VAL A 125 N GLU A 118 SHEET 5 A14 LEU A 60 LEU A 66 -1 N LEU A 66 O ILE A 124 SHEET 6 A14 THR A 35 ALA A 39 -1 N ILE A 37 O SER A 63 SHEET 7 A14 ARG A 12 PHE A 16 1 N ILE A 14 O VAL A 36 SHEET 8 A14 ARG B 12 ILE B 19 -1 O TYR B 15 N VAL A 13 SHEET 9 A14 VAL B 36 GLN B 42 1 O VAL B 36 N ILE B 14 SHEET 10 A14 LEU B 60 LEU B 66 -1 O SER B 63 N ILE B 37 SHEET 11 A14 LYS B 123 LEU B 130 -1 O ILE B 124 N LEU B 66 SHEET 12 A14 LYS B 110 LYS B 120 -1 N GLU B 118 O VAL B 125 SHEET 13 A14 ASP B 104 VAL B 107 -1 N VAL B 105 O ILE B 112 SHEET 14 A14 ARG B 98 LYS B 100 -1 N ARG B 98 O LEU B 106 SHEET 1 B 5 VAL A 222 VAL A 225 0 SHEET 2 B 5 LEU A 213 ARG A 216 -1 N LEU A 213 O VAL A 225 SHEET 3 B 5 SER A 199 ILE A 207 -1 N ASP A 206 O ILE A 214 SHEET 4 B 5 ARG A 191 LEU A 195 -1 N VAL A 192 O GLY A 202 SHEET 5 B 5 SER A 231 PHE A 234 -1 O SER A 231 N LEU A 195 SHEET 1 C 5 VAL B 222 VAL B 225 0 SHEET 2 C 5 LEU B 213 ARG B 216 -1 N LEU B 213 O VAL B 225 SHEET 3 C 5 PHE B 200 ILE B 207 -1 N ASP B 206 O ILE B 214 SHEET 4 C 5 VAL B 190 ILE B 194 -1 N VAL B 192 O GLY B 202 SHEET 5 C 5 LEU B 232 PHE B 234 -1 O ARG B 233 N LYS B 193 LINK C MSE A 1 N LEU A 2 1555 1555 1.33 LINK C THR A 43 N MSE A 44 1555 1555 1.33 LINK C MSE A 44 N GLY A 45 1555 1555 1.33 LINK C SER A 142 N MSE A 143 1555 1555 1.33 LINK C MSE A 143 N LYS A 144 1555 1555 1.33 LINK C PRO A 175 N MSE A 176 1555 1555 1.33 LINK C MSE A 176 N ASP A 177 1555 1555 1.33 LINK C ASN A 185 N MSE A 186 1555 1555 1.33 LINK C MSE A 186 N ILE A 187 1555 1555 1.33 LINK C MSE B 1 N LEU B 2 1555 1555 1.33 LINK C THR B 43 N MSE B 44 1555 1555 1.33 LINK C MSE B 44 N GLY B 45 1555 1555 1.33 LINK C SER B 142 N MSE B 143 1555 1555 1.33 LINK C MSE B 143 N LYS B 144 1555 1555 1.33 LINK C PRO B 175 N MSE B 176 1555 1555 1.33 LINK C MSE B 176 N ASP B 177 1555 1555 1.33 LINK C ASN B 185 N MSE B 186 1555 1555 1.33 LINK C MSE B 186 N ILE B 187 1555 1555 1.33 CISPEP 1 TRP A 101 PRO A 102 0 -0.26 CISPEP 2 TRP B 101 PRO B 102 0 -0.19 SITE 1 AC1 20 GLY A 47 ARG A 48 ARG A 51 LYS A 52 SITE 2 AC1 20 TRP A 53 GLU A 54 ASN A 103 ASP A 104 SITE 3 AC1 20 LYS A 111 ASN A 131 ALA A 140 TYR A 227 SITE 4 AC1 20 SER A 231 ARG A 233 BTN A1401 HOH A1443 SITE 5 AC1 20 HOH A1457 HOH A1460 HOH A1484 HOH A1731 SITE 1 AC2 20 GLY B 47 ARG B 48 ARG B 51 LYS B 52 SITE 2 AC2 20 TRP B 53 GLU B 54 ASN B 103 ASP B 104 SITE 3 AC2 20 LYS B 111 ASN B 131 PRO B 137 ALA B 140 SITE 4 AC2 20 TYR B 227 BTN B1402 HOH B1491 HOH B1553 SITE 5 AC2 20 HOH B1583 HOH B1670 HOH B1706 HOH B1712 SITE 1 AC3 16 SER A 21 THR A 22 ASN A 23 GLN A 42 SITE 2 AC3 16 GLY A 45 HIS A 46 TRP A 53 LEU A 62 SITE 3 AC3 16 ASN A 103 ASP A 104 LYS A 111 GLY A 114 SITE 4 AC3 16 VAL A 115 ILE A 128 GLY A 129 ATP A1301 SITE 1 AC4 16 SER B 21 THR B 22 ASN B 23 GLN B 42 SITE 2 AC4 16 GLY B 45 HIS B 46 TRP B 53 LEU B 62 SITE 3 AC4 16 ASN B 103 ASP B 104 LYS B 111 GLY B 114 SITE 4 AC4 16 VAL B 115 ILE B 128 GLY B 129 ATP B1302 CRYST1 38.251 82.850 72.661 90.00 101.78 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026143 0.000000 0.005452 0.00000 SCALE2 0.000000 0.012070 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014059 0.00000 HETATM 1 N MSE A 1 -21.971 15.162 -22.310 1.00 21.19 N HETATM 2 CA MSE A 1 -20.726 15.861 -21.863 1.00 18.42 C HETATM 3 C MSE A 1 -19.534 14.918 -21.854 1.00 17.49 C HETATM 4 O MSE A 1 -18.401 15.362 -21.980 1.00 18.27 O HETATM 5 CB MSE A 1 -20.876 16.451 -20.438 1.00 19.84 C HETATM 6 CG MSE A 1 -20.749 15.438 -19.252 1.00 3.38 C HETATM 7 SE MSE A 1 -22.348 14.312 -19.401 1.00 34.28 SE HETATM 8 CE MSE A 1 -22.631 14.017 -17.522 1.00 22.76 C